INOVIO PHARMACEUTICALS INC (INO) Stock Income Statement
NASDAQ:INO - Nasdaq - US45773H4092 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 283.10K | 217.80K | 832.00K | 10.26M | 1.77M | |||
| Minority Interest Expense | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Operating Expenses | 106.25M | 112.62M | 134.26M | 277.84M | 302.99M | |||
| Research and Development | 70.80M | 75.62M | 86.68M | 187.65M | 249.24M | |||
| Selling, General, and Administrative Expenses | 35.45M | 37.00M | 47.58M | 90.19M | 53.75M | |||
| Operating Income | -105.96M | -112.40M | -133.43M | -267.57M | -301.22M | |||
| Interest Income/Expense | 11.97M | 8.31M | 13.53M | -6.22M | -2.35M | |||
| Other Income/Expense | -2.48M | -3.16M | -4.71M | -3.86M | 343.00K | |||
| Non Recurring Items | N/A | 0.00 | -10.51M | 0.00 | 0.00 | |||
| Income Before Taxes | -96.48M | -107.25M | -135.12M | -277.65M | -303.22M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | 0.00 | |||
| Net Income | -96.48M | -107.25M | -135.12M | -279.82M | -303.66M | |||
| EBITDA | -102.52M | -109.27M | -130.66M | -263.42M | -297.66M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.24 | -3.95 | -6.09 | -14.07 | -17.45 | |||
| Non GAAP EPS | -3.09 | -3.99 | -6.16 | -14.16 | -17.40 | |||
| Statistics | ||||||||
| Profit Margin | -34079.48% | -49244.31% | -16240.02% | -2726.74% | -17107.55% | |||
| Operating Profit Margin | -37430.06% | -51606.47% | -16036.90% | -2607.43% | -16970.03% | |||
All data in USD